Sana Biotechnology Earnings
NASDAQ: SANAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Thu, Nov 5, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.18
Sana Biotechnology earnings summary
Sana Biotechnology is scheduled to report Sep/2026 earnings on Nov 5, 2026, with analysts expecting EPS of $-0.18. In its most recent report on Aug 10, 2026 (Q2 2026), SANA posted EPS of $-0.22. Across the last 16 reports, SANA shares moved an average of 10.9% (in either direction) in the first trading session after results, rising 9 times and falling 6 times.
Summary generated from market data by MetaCap's automated system. Methodology
SANA earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 10, 2026 | — | $-0.22 | — | +10.1% |
| May 11, 2026 | — | $-0.17 | — | 0.0% |
| Mar 3, 2026 | — | $-0.20 | — | +6.7% |
| Nov 6, 2025 | — | $-0.16 | — | -2.4% |
| Aug 6, 2025 | — | $-0.39 | — | +11.0% |
| May 8, 2025 | — | $-0.21 | — | -4.1% |
| Mar 17, 2025 | — | $-0.21 | — | -26.0% |
| Nov 8, 2024 | — | $-0.25 | — | -19.5% |
| Aug 8, 2024 | — | $-0.21 | — | +1.6% |
| May 8, 2024 | — | $-0.49 | — | +15.5% |
| Feb 29, 2024 | — | $-0.44 | — | -15.7% |
| Nov 8, 2023 | — | $0.00 | — | +24.6% |
| Aug 3, 2023 | — | $-0.59 | — | +1.5% |
| May 8, 2023 | — | $-0.43 | — | +11.8% |
| Mar 16, 2023 | — | $-0.42 | — | -7.7% |
| Nov 2, 2022 | — | $-0.45 | — | +16.9% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.